Balance Sheet Shimadzu Corporation

Equities

7701

JP3357200009

Office Equipment

Delayed Japan Exchange Other stock markets 10:09:55 22/01/2026 am IST			5-day change	1st Jan Change
4,322.00 ^JPY	+1.50%		-1.77%	+3.69%

25/12	Shimadzu Corp - Acquisition price for all shares of Tescan to be approx $678 million	RE
25/12	Shimadzu Corporation agreed to acquire Tescan Group, A.S. from The Carlyle Group Inc. (NasdaqGS:CG) for approximately $680 million.	CI

ef32560c3e0d4360c54.0u0YOj3XzmjrEYYcVhBywwWJwKBpAR7VCdlukW60HCc.64ZSaU-Hp1q4PNFbYHE4qDLOqutbQFrkXa4h0lnnKF2Dh2EOCoGdC9xoww

Published financial data: SHIMADZU CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	39TCr	43TCr	48TCr	51TCr	54TCr
Total Revenues	39TCr	43TCr	48TCr	51TCr	54TCr
Cost of Goods Sold, Total	24TCr	25TCr	28TCr	29TCr	30TCr
Gross Profit	16TCr	18TCr	20TCr	22TCr	23TCr
Selling General & Admin Expenses, Total	9.59TCr	11TCr	13TCr	15TCr	14TCr
Provision for Bad Debts	38Cr	12Cr	18Cr	5Cr	6.4Cr
R&D Expenses	1.02TCr	-	-	-	1.82TCr
Other Operating Expenses, Total	11TCr	11TCr	13TCr	15TCr	16TCr
Operating Income	4.97TCr	6.38TCr	6.82TCr	7.28TCr	7.17TCr
Interest Expense, Total	-18Cr	-19Cr	-28Cr	-29Cr	-28Cr
Interest And Investment Income	55Cr	52Cr	80Cr	161.4Cr	186.5Cr
Net Interest Expenses	37Cr	33Cr	52Cr	132Cr	158.7Cr
Currency Exchange Gains (Loss)	-21Cr	113.9Cr	129.5Cr	244.2Cr	-151.3Cr
Other Non Operating Income (Expenses)	-152.6Cr	30Cr	84Cr	38Cr	22Cr
EBT, Excl. Unusual Items	4.84TCr	6.56TCr	7.09TCr	7.69TCr	7.2TCr
Gain (Loss) On Sale Of Investments	174Cr	95Cr	10Cr	10Cr	127.7Cr
Gain (Loss) On Sale Of Assets	-15Cr	-3Cr	-8.7Cr	-2.9Cr	5.5Cr
Asset Writedown	-15Cr	-	-	-	-38Cr
Other Unusual Items	10L	-55Cr	-6.4Cr	-10L	-124.4Cr
EBT, Incl. Unusual Items	4.98TCr	6.59TCr	7.08TCr	7.7TCr	7.17TCr
Income Tax Expense	1.37TCr	1.87TCr	1.88TCr	1.99TCr	1.8TCr
Earnings From Continuing Operations	3.61TCr	4.73TCr	5.2TCr	5.7TCr	5.38TCr
Net Income to Company	3.61TCr	4.73TCr	5.2TCr	5.7TCr	5.38TCr
Minority Interest	-	-	-	-	10L
Net Income - (IS)	3.61TCr	4.73TCr	5.2TCr	5.7TCr	5.38TCr
Net Income to Common Incl Extra Items	3.61TCr	4.73TCr	5.2TCr	5.7TCr	5.38TCr
Net Income to Common Excl. Extra Items	3.61TCr	4.73TCr	5.2TCr	5.7TCr	5.38TCr
Per Share Items
Net EPS - Basic	122.52	160.49	176.63	193.54	183.55
Basic EPS - Continuing Operations	122.52	160.49	176.63	193.54	183.55
Basic Weighted Average Shares Outstanding	29Cr	29Cr	29Cr	29Cr	29Cr
Net EPS - Diluted	122.52	160.49	176.63	193.54	183.55
Diluted EPS - Continuing Operations	122.52	160.49	176.63	193.54	183.55
Diluted Weighted Average Shares Outstanding	29Cr	29Cr	29Cr	29Cr	29Cr
Normalized Basic EPS	102.62	139.1	150.34	163.08	153.63
Normalized Diluted EPS	102.62	139.1	150.34	163.08	153.63
Dividend Per Share	34	48	54	60	62
Payout Ratio	24.49	24.3	28.33	28.91	33.94
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	6.53TCr	8TCr	8.57TCr	9.13TCr	9.16TCr
EBITA	4.97TCr	6.38TCr	6.82TCr	7.28TCr	7.17TCr
EBIT	4.97TCr	6.38TCr	6.82TCr	7.28TCr	7.17TCr
Effective Tax Rate - (Ratio)	27.54	28.29	26.52	25.89	25.03
Normalized Net Income	3.02TCr	4.1TCr	4.43TCr	4.81TCr	4.5TCr
Non-Cash Pension Expense	54Cr	51Cr	98Cr	20Cr	-225.3Cr
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	1.02TCr	1.03TCr	1.1TCr	1.23TCr	1.82TCr

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	11TCr	16TCr	16TCr	17TCr	14TCr
Short Term Investments	-	-	42Cr	-	-
Total Cash And Short Term Investments	11TCr	16TCr	16TCr	17TCr	14TCr
Accounts Receivable, Total	12TCr	12TCr	13TCr	14TCr	15TCr
Total Receivables	12TCr	12TCr	13TCr	14TCr	15TCr
Inventory	9.76TCr	11TCr	13TCr	14TCr	14TCr
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	929.8Cr	998.6Cr	1.51TCr	1.71TCr	2.03TCr
Total Current Assets	34TCr	39TCr	43TCr	47TCr	45TCr
Net Property Plant And Equipment	10TCr	10TCr	11TCr	12TCr	12TCr
Long-term Investments	3.64TCr	3.78TCr	4.15TCr	5.93TCr	6.19TCr
Goodwill	-	-	494.7Cr	522Cr	777.9Cr
Other Intangibles, Total	1.16TCr	1.12TCr	1.2TCr	1.28TCr	1.6TCr
Loans Receivable Long-Term	13Cr	16Cr	17Cr	20Cr	23Cr
Deferred Tax Assets Long-Term	1.15TCr	1.26TCr	1.57TCr	1.09TCr	1.22TCr
Other Long-Term Assets, Total	10L	10L	20L	20L	10L
Total Assets	50TCr	56TCr	62TCr	67TCr	67TCr
Liabilities
Accounts Payable, Total	6.14TCr	6.65TCr	6.67TCr	5.24TCr	4.76TCr
Accrued Expenses, Total	1.17TCr	1.2TCr	1.4TCr	1.4TCr	1.44TCr
Short-term Borrowings	146.2Cr	150.4Cr	140Cr	155.2Cr	136.8Cr
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	356.8Cr	345.8Cr	323.7Cr	347.8Cr	353.5Cr
Current Income Taxes Payable	2.06TCr	2.47TCr	2.62TCr	2.51TCr	2.52TCr
Other Current Liabilities	4.53TCr	5.05TCr	6.08TCr	6.2TCr	5.92TCr
Total Current Liabilities	14TCr	16TCr	17TCr	16TCr	15TCr
Long-Term Debt	28Cr	20Cr	13Cr	6.6Cr	40L
Long-Term Leases	494.5Cr	642.2Cr	649.9Cr	681.8Cr	684Cr
Pension & Other Post Retirement Benefits	1.15TCr	1.31TCr	1.44TCr	1.43TCr	1.36TCr
Other Non Current Liabilities	115.9Cr	86Cr	198.9Cr	191.4Cr	234Cr
Total Liabilities	16TCr	18TCr	20TCr	18TCr	17TCr
Common Stock, Total	2.66TCr	2.66TCr	2.66TCr	2.66TCr	2.66TCr
Additional Paid In Capital	3.49TCr	3.49TCr	3.49TCr	3.49TCr	3.49TCr
Retained Earnings	26TCr	30TCr	34TCr	38TCr	41TCr
Treasury Stock	-125.9Cr	-124.4Cr	-121Cr	-110.9Cr	-2.61TCr
Comprehensive Income and Other	1.22TCr	2.21TCr	2.71TCr	5.55TCr	5.09TCr
Total Common Equity	34TCr	38TCr	42TCr	49TCr	50TCr
Minority Interest	-	-	-	40L	70L
Total Equity	34TCr	38TCr	42TCr	49TCr	50TCr
Total Liabilities And Equity	50TCr	56TCr	62TCr	67TCr	67TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	29Cr	29Cr	29Cr	29Cr	29Cr
ECS Total Common Shares Outstanding	29Cr	29Cr	29Cr	29Cr	29Cr
Book Value / Share	1.14T	1.29T	1.44T	1.67T	1.72T
Tangible Book Value	32TCr	37TCr	41TCr	47TCr	47TCr
Tangible Book Value Per Share	1.1T	1.26T	1.38T	1.61T	1.64T
Total Debt	1.03TCr	1.16TCr	1.13TCr	1.19TCr	1.17TCr
Net Debt	-10TCr	-15TCr	-15TCr	-15TCr	-13TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-783.4Cr	-767.2Cr	-759.7Cr	-2.21TCr	-2.77TCr
Minority Interest, Total (Incl. Fin. Div)	-	-	-	40L	70L
Inventories - Raw Materials, Total	2.02TCr	2.45TCr	2.93TCr	3.24TCr	3.41TCr
Inventories - Work In Process, Total	1.84TCr	2.08TCr	2.65TCr	2.6TCr	2.76TCr
Inventories - Finished Goods, Total	5.91TCr	6.14TCr	7.23TCr	8.33TCr	8.17TCr
Full Time Employees	13.31T	13.5T	13.9T	14.22T	14.48T
Accumulated Allowance for Doubtful Accounts (Supple)	211.9Cr	216.7Cr	221.7Cr	204.9Cr	176Cr
Order Backlog	13TCr	16TCr	21TCr	22TCr	24TCr

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	4.98TCr	6.59TCr	7.08TCr	7.7TCr	7.17TCr
Depreciation & Amortization - CF	1.55TCr	1.62TCr	1.75TCr	1.86TCr	1.99TCr
Depreciation & Amortization, Total	1.55TCr	1.62TCr	1.75TCr	1.86TCr	1.99TCr
(Gain) Loss From Sale Of Asset	30Cr	3Cr	8.6Cr	2.8Cr	32Cr
(Gain) Loss on Sale of Investments - (CF)	-174Cr	-95Cr	-10Cr	-8.3Cr	-122.9Cr
Other Operating Activities, Total	-1.01TCr	-1.7TCr	-2.18TCr	-2.34TCr	-1.88TCr
Change In Accounts Receivable	-544.4Cr	-22Cr	-105.2Cr	-690.2Cr	-439.3Cr
Change In Inventories	312.6Cr	-525.2Cr	-1.62TCr	-718.2Cr	-421.7Cr
Change In Accounts Payable	-9.2Cr	225.5Cr	-422.8Cr	-1.92TCr	-430.4Cr
Change in Other Net Operating Assets	1.24TCr	230.2Cr	320.3Cr	-860.2Cr	-703.7Cr
Cash from Operations	6.38TCr	6.34TCr	4.83TCr	3.01TCr	5.2TCr
Capital Expenditure	-1.33TCr	-1.01TCr	-1.68TCr	-1.55TCr	-1.51TCr
Sale of Property, Plant, and Equipment	35Cr	56Cr	52Cr	44Cr	76Cr
Cash Acquisitions	-	-	-1.4TCr	-	-654.6Cr
Investment in Marketable and Equity Securities, Total	51Cr	-2.3Cr	-168.3Cr	67Cr	-186.3Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	2.4Cr	-1Cr	-1.1Cr	-1.7Cr	-2.9Cr
Other Investing Activities, Total	-143.2Cr	356.5Cr	-249.6Cr	-159.5Cr	-40Cr
Cash from Investing	-1.39TCr	-604.4Cr	-3.45TCr	-1.6TCr	-2.32TCr
Short Term Debt Issued, Total	1TCr	-	-	16Cr	10L
Long-Term Debt Issued, Total	28Cr	-	-	-	40L
Total Debt Issued	1.03TCr	-	-	16Cr	50L
Short Term Debt Repaid, Total	-1.04TCr	-	-10Cr	-	-19Cr
Long-Term Debt Repaid, Total	-23Cr	-3.4Cr	-7.8Cr	-7.2Cr	-6.6Cr
Total Debt Repaid	-1.07TCr	-3.4Cr	-18Cr	-7.2Cr	-25Cr
Repurchase of Common Stock	16Cr	1.4Cr	3.4Cr	10Cr	-2.5TCr
Common Dividends Paid	-884Cr	-1.15TCr	-1.47TCr	-1.65TCr	-1.82TCr
Common & Preferred Stock Dividends Paid	-884Cr	-1.15TCr	-1.47TCr	-1.65TCr	-1.82TCr
Other Financing Activities, Total	-397.3Cr	-414.8Cr	-452.9Cr	-479.3Cr	-490.8Cr
Cash from Financing	-1.3TCr	-1.57TCr	-1.94TCr	-2.11TCr	-4.84TCr
Foreign Exchange Rate Adjustments	306.8Cr	679.9Cr	404Cr	1.2TCr	-290.7Cr
Miscellaneous Cash Flow Adjustments	20Cr	-10L	-	44Cr	44Cr
Net Change in Cash	4.02TCr	4.85TCr	-158.4Cr	549.9Cr	-2.2TCr
Supplemental Items
Cash Interest Paid	18Cr	19Cr	28Cr	29Cr	26Cr
Cash Income Tax Paid (Refund)	1.01TCr	1.67TCr	2.18TCr	2.35TCr	1.88TCr
Levered Free Cash Flow	5.3TCr	4.68TCr	2.13TCr	465.35Cr	3.3TCr
Unlevered Free Cash Flow	5.31TCr	4.7TCr	2.15TCr	483.72Cr	3.31TCr
Change In Net Working Capital	-1.98TCr	-100.4Cr	2.19TCr	4.37TCr	1.65TCr
Net Debt Issued / Repaid	-38Cr	-3.4Cr	-18Cr	8.6Cr	-25Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.65	7.54	7.23	7.03	6.66
Return on Total Capital	9.48	10.8	10.3	9.68	8.84
Return On Equity %	11.31	13.2	12.94	12.46	10.86
Return on Common Equity	11.31	13.2	12.94	12.46	10.86
Margin Analysis
Gross Profit Margin %	39.69	41.72	41.67	43.14	43.49
SG&A Margin	24.38	26.79	27.49	28.92	26.79
EBITDA Margin %	16.59	18.69	17.78	17.84	17
EBITA Margin %	12.64	14.9	14.15	14.21	13.31
EBIT Margin %	12.64	14.9	14.15	14.21	13.31
Income From Continuing Operations Margin %	9.17	11.04	10.79	11.14	9.98
Net Income Margin %	9.17	11.04	10.79	11.14	9.98
Net Avail. For Common Margin %	9.17	11.04	10.79	11.14	9.98
Normalized Net Income Margin	7.68	9.57	9.19	9.39	8.35
Levered Free Cash Flow Margin	13.46	10.94	4.41	0.91	6.11
Unlevered Free Cash Flow Margin	13.49	10.97	4.45	0.94	6.15
Asset Turnover
Asset Turnover	0.84	0.81	0.82	0.79	0.8
Fixed Assets Turnover	3.93	4.14	4.44	4.42	4.53
Receivables Turnover (Average Receivables)	3.37	3.64	3.88	3.77	3.72
Inventory Turnover (Average Inventory)	2.56	2.44	2.4	2.16	2.14
Short Term Liquidity
Current Ratio	2.33	2.48	2.5	2.95	3
Quick Ratio	1.59	1.75	1.67	1.94	1.92
Operating Cash Flow to Current Liabilities	0.44	0.4	0.28	0.19	0.34
Days Sales Outstanding (Average Receivables)	108.45	100.38	94.15	97.16	98.23
Days Outstanding Inventory (Average Inventory)	142.68	149.4	152.3	169.68	170.83
Average Days Payable Outstanding	89.83	90.32	80.33	71.53	59.62
Cash Conversion Cycle (Average Days)	161.3	159.46	166.13	195.31	209.43
Long Term Solvency
Total Debt/Equity	3.06	3.04	2.66	2.42	2.36
Total Debt / Total Capital	2.97	2.95	2.59	2.36	2.3
LT Debt/Equity	1.56	1.74	1.57	1.4	1.37
Long-Term Debt / Total Capital	1.51	1.69	1.53	1.37	1.34
Total Liabilities / Total Assets	32.56	32	31.57	26.95	25.9
EBIT / Interest Expense	276.35	339.4	242.78	247.46	257.99
EBITDA / Interest Expense	362.66	425.6	305.14	310.56	329.55
(EBITDA - Capex) / Interest Expense	288.71	371.71	245.22	257.83	275.23
Total Debt / EBITDA	0.16	0.14	0.13	0.13	0.13
Net Debt / EBITDA	-1.57	-1.83	-1.73	-1.68	-1.44
Total Debt / (EBITDA - Capex)	0.2	0.17	0.16	0.16	0.15
Net Debt / (EBITDA - Capex)	-1.97	-2.09	-2.15	-2.02	-1.72
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.09	8.81	12.63	6.15	5.3
Gross Profit, 1 Yr. Growth %	2.47	14.36	12.51	9.89	6.16
EBITDA, 1 Yr. Growth %	18.47	22.57	7.17	6.48	0.34
EBITA, 1 Yr. Growth %	18.87	28.27	6.92	6.64	-1.42
EBIT, 1 Yr. Growth %	18.87	28.27	6.92	6.64	-1.42
Earnings From Cont. Operations, 1 Yr. Growth %	13.64	31.01	10.06	9.59	-5.72
Net Income, 1 Yr. Growth %	13.63	31.01	10.06	9.59	-5.72
Normalized Net Income, 1 Yr. Growth %	13.36	35.55	8.09	8.49	-6.34
Diluted EPS Before Extra, 1 Yr. Growth %	13.61	30.99	10.06	9.57	-5.16
Accounts Receivable, 1 Yr. Growth %	-1.99	3.48	7.73	10.64	3.23
Inventory, 1 Yr. Growth %	11.13	9.21	20.11	10.68	1.12
Net Property, Plant and Equip., 1 Yr. Growth %	4.72	1.99	8.2	4.93	0.84
Total Assets, 1 Yr. Growth %	13.67	12.68	10.41	8.9	-0.26
Tangible Book Value, 1 Yr. Growth %	11.17	14.24	9.87	16.67	-0
Common Equity, 1 Yr. Growth %	10.81	13.61	11.11	16.25	1.16
Cash From Operations, 1 Yr. Growth %	61.48	-0.68	-23.77	-37.63	72.61
Capital Expenditures, 1 Yr. Growth %	-16.11	-23.9	66.2	-7.93	-2.58
Levered Free Cash Flow, 1 Yr. Growth %	134.86	-11.55	-54.57	-78.13	608.22
Unlevered Free Cash Flow, 1 Yr. Growth %	134.76	-11.51	-54.31	-77.45	584.91
Dividend Per Share, 1 Yr. Growth %	13.33	41.18	12.5	11.11	3.33
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.29	5.4	10.7	9.34	5.73
Gross Profit, 2 Yr. CAGR %	-0.31	8.25	13.43	11.19	8.01
EBITDA, 2 Yr. CAGR %	7.98	20.5	14.61	6.82	3.37
EBITA, 2 Yr. CAGR %	5.75	23.48	17.11	6.78	2.53
EBIT, 2 Yr. CAGR %	5.75	23.48	17.11	6.78	2.53
Earnings From Cont. Operations, 2 Yr. CAGR %	5.25	22.02	20.08	9.82	1.65
Net Income, 2 Yr. CAGR %	5.35	22.01	20.08	9.82	1.65
Normalized Net Income, 2 Yr. CAGR %	3.27	23.96	21.04	8.29	0.8
Diluted EPS Before Extra, 2 Yr. CAGR %	5.34	21.99	20.07	9.81	1.94
Accounts Receivable, 2 Yr. CAGR %	-3.66	0.71	5.58	9.18	6.87
Inventory, 2 Yr. CAGR %	8.16	10.17	14.53	15.3	5.79
Net Property, Plant and Equip., 2 Yr. CAGR %	5	3.35	5.05	6.55	2.86
Total Assets, 2 Yr. CAGR %	6.67	13.18	11.54	9.65	4.22
Tangible Book Value, 2 Yr. CAGR %	8.12	12.7	12.03	13.22	8.01
Common Equity, 2 Yr. CAGR %	7.95	12.2	12.35	13.65	8.45
Cash From Operations, 2 Yr. CAGR %	47.18	26.64	-12.99	-31.05	3.76
Capital Expenditures, 2 Yr. CAGR %	-19.97	-20.1	12.47	23.7	-5.3
Levered Free Cash Flow, 2 Yr. CAGR %	86.78	44.13	-36.61	-68.48	24.46
Unlevered Free Cash Flow, 2 Yr. CAGR %	86.53	44.13	-36.42	-67.9	24.27
Dividend Per Share, 2 Yr. CAGR %	10.19	26.49	26.03	11.8	7.15
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.48	3.06	7.75	9.16	7.98
Gross Profit, 3 Yr. CAGR %	1.4	4.36	9.65	12.24	9.49
EBITDA, 3 Yr. CAGR %	6.92	12.64	15.88	11.83	4.62
EBITA, 3 Yr. CAGR %	5.12	12.78	17.69	13.51	3.97
EBIT, 3 Yr. CAGR %	5.12	12.78	17.69	13.51	3.97
Earnings From Cont. Operations, 3 Yr. CAGR %	6.46	13.22	17.89	16.47	4.38
Net Income, 3 Yr. CAGR %	6.55	13.29	17.89	16.47	4.38
Normalized Net Income, 3 Yr. CAGR %	5.04	13.07	18.43	16.7	3.17
Diluted EPS Before Extra, 3 Yr. CAGR %	6.56	13.28	17.88	16.46	4.58
Accounts Receivable, 3 Yr. CAGR %	-0.56	-1.33	3	7.24	7.16
Inventory, 3 Yr. CAGR %	6.59	8.51	13.39	13.23	10.36
Net Property, Plant and Equip., 3 Yr. CAGR %	6.76	3.98	4.94	5.01	4.61
Total Assets, 3 Yr. CAGR %	5.82	8.64	12.25	10.65	6.24
Tangible Book Value, 3 Yr. CAGR %	7.81	10.12	11.75	13.56	8.63
Common Equity, 3 Yr. CAGR %	7.82	9.81	11.83	13.64	9.33
Cash From Operations, 3 Yr. CAGR %	15.68	29.09	6.93	-22.13	-6.38
Capital Expenditures, 3 Yr. CAGR %	3.6	-21.3	2	5.21	14.23
Levered Free Cash Flow, 3 Yr. CAGR %	17.87	45.59	-1.91	-55.54	-11.06
Unlevered Free Cash Flow, 3 Yr. CAGR %	17.85	45.47	-1.73	-55	-10.98
Dividend Per Share, 3 Yr. CAGR %	12.31	19.68	21.64	20.84	8.91
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	2.83	4.57	5.07	5.52	6.94
Gross Profit, 5 Yr. CAGR %	2.16	5.54	6.05	7.04	8.99
EBITDA, 5 Yr. CAGR %	7.66	11.4	9.93	10.28	10.7
EBITA, 5 Yr. CAGR %	6.86	11.46	9.76	10.34	11.38
EBIT, 5 Yr. CAGR %	6.86	11.46	9.76	10.34	11.38
Earnings From Cont. Operations, 5 Yr. CAGR %	8.54	12.25	11.71	11.85	11.1
Net Income, 5 Yr. CAGR %	8.6	12.3	11.77	11.89	11.1
Normalized Net Income, 5 Yr. CAGR %	6.85	12.16	11.17	11.13	11.03
Diluted EPS Before Extra, 5 Yr. CAGR %	8.61	12.32	11.77	11.88	11.22
Accounts Receivable, 5 Yr. CAGR %	2.11	1.4	1.85	2.74	4.53
Inventory, 5 Yr. CAGR %	5.8	6.81	9.7	11.18	10.28
Net Property, Plant and Equip., 5 Yr. CAGR %	6.1	5.81	6.08	5	4.1
Total Assets, 5 Yr. CAGR %	7.3	8.35	8.07	9.04	8.96
Tangible Book Value, 5 Yr. CAGR %	8.83	9.7	9.48	11.35	10.24
Common Equity, 5 Yr. CAGR %	8.84	9.57	9.61	11.33	10.47
Cash From Operations, 5 Yr. CAGR %	14.55	16.44	3.22	0.45	5.65
Capital Expenditures, 5 Yr. CAGR %	3.27	-1.66	7.06	-5.7	-0.98
Levered Free Cash Flow, 5 Yr. CAGR %	19.66	23.07	-8.03	-21.06	7.89
Unlevered Free Cash Flow, 5 Yr. CAGR %	19.59	23	-7.93	-20.52	7.95
Dividend Per Share, 5 Yr. CAGR %	13.56	19.14	17.61	16.47	15.63